2022年

2022年

原著

  1. Van Braeckel E, Page I, Davidsen J, Laursen C, Agarwal R, Alastruey-Izquierdo A, Barac A, Cadranel J, Chakrabarti A, Cornely O, Denning D, Flick H, Gangneux JP, Godet C, Hayashi Y, Hennequin C, Hoenigl M, Irfan M, Izumikawa K, Koh WJ, Kosmidis C. Lange C, Lamprecht B, Laurent F, Munteanu O, Oladele R, Patterson T, Watanabe A, Salzer H: Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement. Eur Respir J 59(6): 2102950, 2022.[PubMed]
  2. Takamatsu A, Yaguchi T, Tagashira Y, Watanabe A, Honda H: Nocardiosis in Japan: a multicentric retrospective cohort study. Antimicrob Agents Chemother 66(2): e01890-21, 2022.[PubMed]
  3. Takeda K, Suzuki J, Watanabe A, Narumoto O, Kawashima M, Sasaki Y, Nagai H, kamei K, Matsui H: Non-fumigatus Aspergillus infection associated with a negative Aspergillus precipitin test in patients with chronic pulmonary aspergillosis. J Clin Microbiol 60(2): e0201821, 2022.[PubMed]
  4. Khalifa HO, Hubka V, Watanabe A, Nagi M, Miyazaki Y, Yaguchi T, Kamei K: Prevalence of Antifungal Resistance, Genetic Basis of Acquired Azole and Echinocandin Resistance, and Genotyping of Candid krusei recovered from an International Collection. Antimicrob Agents Chemother 66(2): e0185621, 2022.[PubMed]
  5. Takeda K, Suzuki J, Watanabe A, Sekiguchi R, Sano T, Narumoto O, Kawashima M, Fukami T, Sasaki Y, Tamura A, Nagai H, Matsui H, Kamei K: The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single-centre study. Mycoses 65(2):164-170, 2022.[PubMed]
  6. Khalifa HO, Watanabe A, Kamei K: Azole and Echinocandin Resistance Mechanisms and Genotyping of Candida tropicalis in Japan: Cross-Boundary Dissemination and Animal-Human Transmission of C. tropicalis Infection. Clin Microbiol Infect 28(2): 302.e5-302.e8, 2022.[PubMed]
  7. Toh-E A, Ohkusu M, Ishiwada N, Watanabe A, Kamei K: Genetic system underlying responses of Cryptococcus neoformans to cadmium. Curr Genet 68(1): 125-141, 2022.[PubMed]

症例報告

  1. Arasaki R, Tanaka S, Okawa K, Tanaka Y, Inoue T, Kobayashi S, Maruyama-Inoue M, Yamaguchi T, Muraosa Y, Kamei K, Kadonosono K: Endophthalmitis outbreak caused by Fusarium oxysporum after cataract surgery. Am J Ophthalmol Case Rep 26: 101397, 2022.[PubMed]
  2. Watanabe C, Kimizuka Y, Fujikura Y, Hamamoto T, Watanabe A, Yaguchi T, Sano T, Suematsu R, Kato Y, Miyata J, Matsukuma S, Kawana A: Mixed infection of cytomegalovirus and pulmonary nocardiosis caused by Nocardia elegans diagnosed using nanopore sequencing technology: A case report. Intern Med 61(10):1613-1617, 2022.[PubMed]
  3. Pontes L, Gualtieri Beraquet CA, Arai T, Watanabe A, Moretti ML, Schreiber AZ: Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP 51A gene after long-term treatment with voriconazole in an immunocompromised patient. Med Mycol Case Rep 36: 5-9, 2022.[PubMed]
  4. Kaneko H, Yamazaki S, Uchida M, Suzuki T, Murakami K, Matsubara H, Kamei K, Ishii I: Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report. J Pharm Health Care Sci 8(1):6, 2022.[PubMed]
  5. Miyazawa H, Matsuda Y, Sakai S, Kamei K, Wada T: Mesenteric abscess caused by coinfection with Bacillus Calmette-Guérin and Phialemonium sp. in chronic granulomatous disease. IDCases 27:e01375, 2022.[PubMed]
  6. Hase I, Kagatani J, Suzuki S, Yoshida S, Sakamoto K, Maitani F, Horinouchi H, Kamei K, Tateno H: Successfully treated bronchopulmonary oxalosis caused by Aspergillus tubingensis in a non-neutropenic patient: A case report and review of the literature. J Infect Chemother 28(2): 299-303, 2022.[PubMed]

総説・解説など

  1. 亀井克彦:輸入真菌症.呼吸器内科 41(3): 275-280,2022.

著書

  1. 亀井克彦:肺真菌症. 「今日の治療指針 私はこう治療している」2022年版〔ポケット判〕. pp.301-303,総編集:福井次矢,高木誠,小室一成,医学書院,2022.1.1.発行.
  2. 渡辺哲:輸入真菌症.「今日の皮膚疾患治療指針 第5版」.編集:佐藤伸一, 藤本学, 門野岳史,椛島健治,p.959-963,医学書院,2022.3.1発行.